findmyKOL
Clinical trialNCT00109161CompletedPhase 2Interventional

Study of Subcutaneous Daclizumab in Patients With Active, Relapsing Forms of Multiple Sclerosis

SponsorPDL BioPharma, Inc.Enrollment270Multiple Sclerosis
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

36 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • Foothills Medical Centre-Ms Research Program

    Calgary, Alberta, Canada

  • University of Alberta

    Edmonton, Alberta, Canada

  • Health Sciences Center

    Winnipeg, Manitoba, Canada

  • London Health Sciences Centre

    London, Ontario, Canada

  • Clinique Sep/nm

    Gatineau, Quebec, Canada

  • Montreal Neurological Institute

    Montreal, Quebec, Canada

United States
  • St. Joseph'S Hospital and Medical Center

    Phoenix, Arizona, United States

  • Mayo Clinic

    Scottsdale, Arizona, United States

  • Sutter East Bay Medical Foundation

    Berkeley, California, United States

  • Neurology Associates, P.A.

    Maitland, Florida, United States

  • the Multiple Sclerosis Center of Atlanta

    Atlanta, Georgia, United States

  • Consultants in Neurology

    Northbrook, Illinois, United States

  • Kumc Neurology

    Kansas City, Kansas, United States

  • Louisiana State University Health Sciences Center

    Shreveport, Louisiana, United States

  • Maryland Center for Ms

    Baltimore, Maryland, United States

  • Wayne State University Ms Center

    Detroit, Michigan, United States

  • Michigan State University

    East Lansing, Michigan, United States

  • Michigan Medical P.C. Neurology

    Grand Rapids, Michigan, United States

  • St. Louis University Hospital

    St Louis, Missouri, United States

  • Ms Center at Dartmouth

    Lebanon, New Hampshire, United States

  • Gimble Ms Center

    Teaneck, New Jersey, United States

  • Albany Medical Center

    Albany, New York, United States

  • Upstate Clinical Research

    Albany, New York, United States

  • Winthrop University Hospital

    Mineola, New York, United States

  • Hospital for Joint Diseases, Ms Care Center

    New York, New York, United States

  • University of Rochester Medical Center

    Rochester, New York, United States

  • Ms Center/cmc Meyers Park

    Charlotte, North Carolina, United States

  • Raleigh Neurology Associates

    Raleigh, North Carolina, United States

  • University of Cincinnati

    Cincinnati, Ohio, United States

  • University of Pennsylvania

    Philadelphia, Pennsylvania, United States

  • the Ms Center at Texas Neurology

    Dallas, Texas, United States

  • Central Texas Neurology

    Round Rock, Texas, United States

  • University of Utah Camt

    Salt Lake City, Utah, United States

  • Ms Hub Medical Group

    Seattle, Washington, United States

  • Rockwood Clinic, Ps

    Spokane, Washington, United States

  • Wenatchee Valley Medical Center

    Wenatchee, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Apr 2005
Primary completion
Completion
31 Oct 2006
Last update posted
5 Aug 2008
Registered enrollment
270
Registry id
NCT00109161

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.